Variation in Anticoagulant Recommendations by the Guidelines and Decision Tools among Patients with Atrial...

Area of Science:

• Cardiology
• Clinical Decision Support
• Pharmacology

Background:

• Published atrial fibrillation (AF) guidelines and decision tools provide oral anticoagulant (OAC) recommendations.
• These guidelines and tools differ in how they assess stroke and bleeding risks.

Purpose of the Study:

• To compare OAC recommendations from major guidelines (ACCP, ESC, AHA) and decision tools (Casciano, LaHaye).
• To evaluate the concordance between guideline/tool recommendations and actual OAC use in AF patients.
• To analyze variations in recommendations and concordance across different stroke/bleed risk strata.

Main Methods:

• Cross-sectional study utilizing 2001-2013 Lifelink claims data.
• Analysis of 15,129 AF patients stratified into nine stroke/bleed risk groups using CHA₂DS₂-VASc and HAS-BLED scores.
• Comparison of OAC recommendations from ACCP, ESC, AHA guidelines, and Casciano/LaHaye decision tools.

Main Results:

• Significant variation in OAC recommendations was observed, particularly for moderate to high stroke risk (CHA₂DS₂-VASc > 0).
• The AHA guidelines recommended OAC most frequently (86.30%), while the LaHaye tool recommended it least often (14.91%).
• Actual OAC use/non-use showed high discordance (>40%) with all evaluated guidelines and tools.

Conclusions:

• Existing AF guidelines and decision tools show considerable variation in OAC recommendations.
• There is a substantial gap between recommended and actual OAC use in AF patients.
• Opportunities exist to enhance OAC prescribing decisions in AF management.